Global Endotracheal Tube Devices in the Pipeline, 2020

DUBLIN, Feb. 20, 2020 /PRNewswire/ -- The "Endotracheal Tubes - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of Endotracheal Tubes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

Report Scope

• Extensive coverage of the Endotracheal Tubes Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Endotracheal Tubes Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Endotracheal Tubes Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Recent Developments

• Nov 19, 2019: Medtronic Reports Second Quarter Financial Results For The Year 2019
• Nov 14, 2019: Sonoma Pharmaceuticals Reports Second Quarter Fy 2020 Financial Results
• Nov 14, 2019: Medtronic Highlights Leadership In Inclusion, Diversity, And Equity In 2019 Integrated Performance Report
• Nov 13, 2019: Ambu: Changes Within The Board Of Directors
• Oct 31, 2019: Teleflex Reports Third Quarter 2019 Results
• Oct 21, 2019: Sean Salmon Named Executive Vice President And Group President Of Medtronic Diabetes
• Oct 01, 2019: Sonoma Pharmaceuticals Announces Management Changes
• Sep 29, 2019: New Major Order From China
• Sep 17, 2019: Adventhealth, Moffitt Cancer Center Join Forces To Improve Cancer Care For Floridians
• Aug 28, 2019: Medtronic Announces Planned Leadership Succession
• Aug 22, 2019: Ambu: Interim Report For Q3 2018/19
• Aug 20, 2019: Medtronic Reports First Quarter Financial Results For 2019
• Aug 13, 2019: Sonoma Pharmaceuticals Reports First Quarter Fy 2020 Financial Results
• Aug 02, 2019: Centurion Medical Products Recalls Airway Kit Containing Sheridan Endotracheal Tubes Due To Potential For The Tube Connector To Dislodge, Which May Result In Disconnection Of The Patient From The Breathing Circuit
• Aug 01, 2019: Teleflex Reports Second Quarter 2019 Results
• Aug 01, 2019: Access Scientific Unveils Partnership With Smiths Medical To Sell Access' Powerwand Product Lines And Completion Of A $20M Capital Raise
• Jul 24, 2019: Former Medtronic Executive Sean Ginney Named Vp Of Sales At Current Health
• Jul 10, 2019: Medtronic Announces The Early Results Of Its Cash Tender Offers For Up To $5.525 Billion Of Certain Outstanding Debt Securities
• Jul 08, 2019: Sonoma Pharmaceuticals Reports Fiscal Year And Fourth Quarter 2019 Financial Results
• Jun 17, 2019: Ambu: Review Of The Big Five 2020 Strategy
• May 23, 2019: Medtronic Announces Fiscal Year And Fourth Quarter 2019 Financial Results
• May 10, 2019: Ambu Appoints New Ceo
• May 02, 2019: Teleflex Reports First Quarter 2019 Results
• May 01, 2019: Ambu: Interim Report For Q2 2018/19 And For The Half-Year
• May 01, 2019: Ambu: Interim Report For Q2 2018/19 And For The Period 1 October 2018 - 31 March 2019
• Apr 25, 2019: N8 Medical Announces First-In-Human Use Of Its Cerashield Endotracheal Tube
• Mar 28, 2019: Pneumonia Prevention: Ohsu To Test Specialized Breathing Tubes
• Mar 25, 2019: Medtronic Launches Medtech Innovation Accelerator In Shanghai
• Mar 22, 2019: Smiths Announces Its Plans For The Separation Of Smiths Medical
• Mar 14, 2019: Medtronic Names Andrea J. Goldsmith As A New Director
• Mar 12, 2019: Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures
• Feb 21, 2019: First Clinical Study On Fcv Using Evone And Tritube Presented As One Of The Five Most Important Publications Concerning Preoperative Ventilation
• Feb 21, 2019: Teleflex Reports Fourth Quarter And Full Year 2018 Results; Provides 2019 Guidance
• Feb 19, 2019: Medtronic Reports Third Quarter Financial Results
• Feb 19, 2019: Intalere Members Benefit Through New Agreement With Smiths Medical
• Feb 04, 2019: Ambu Announced Board Change
• Feb 01, 2019: Smiths Medical Issues A Voluntary Nationwide Recall Of Sterile Water And Saline For Inhalation Usp Products
• Jan 31, 2019: Ambu: Interim Report For Q1 2018/19

Companies Mentioned

• Allvivo Vascular Inc.
• Baylor College of Medicine
• Enox Biopharma Inc. (Inactive)
• Fogless International AB
• Illumitube
• Johns Hopkins University
• Laval University
• Medical Device Investments Inc.
• N8 Medical Inc.
• Resultados y Calidad del Sistema Sanitario Publico de Andalucia
• Semprus BioSciences (Inactive)
• Sharklet Technologies Inc.
• Sonoma Pharmaceuticals Inc.
• The Chinese University of Hong Kong
• University of Colorado
• University of Illinois at Chicago
• University of Michigan
• Vrije University Brussel

For more information about this report visit https://www.researchandmarkets.com/r/4a0eu

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com